This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate (DMPA), Depo-Provera) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.
Please read this guidance document in conjunction with any relevant clinical statements for this topic:
You are welcome to download our freely available Guideline documents by clicking on the document title above.
This document is up-to-date